Growth Metrics

Eli Lilly (LLY) EBT Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 185.00
Dec 31, 2025 176.00
Sep 30, 2025 -247.00
Jun 30, 2025 1,641.00
Mar 31, 2025 -1,008.00
Dec 31, 2024 2,334.00
Sep 30, 2024 -1,723.00
Jun 30, 2024 219.00
Mar 31, 2024 211.00
Dec 31, 2023 2,232.00
Sep 30, 2023 -2,063.00
Jun 30, 2023 315.00
Mar 31, 2023 -673.00
Dec 31, 2022 616.00
Sep 30, 2022 574.00
Jun 30, 2022 -948.00
Mar 31, 2022 330.00
Dec 31, 2021 461.00
Sep 30, 2021 -526.00
Jun 30, 2021 195.00
Mar 31, 2021 -1,149.00
Dec 31, 2020 815.00
Sep 30, 2020 -485.00
Jun 30, 2020 122.00
Mar 31, 2020 147.00
Dec 31, 2019 153.00
Sep 30, 2019 -34.00
Jun 30, 2019 1,165.00
Mar 31, 2019 -217.00
Dec 31, 2018 -875.00
Sep 30, 2018 2,452.00
Jun 30, 2018 -2,677.00
Mar 31, 2018 2,116.00
Dec 31, 2017 -410.00
Sep 30, 2017 -1,119.00
Jun 30, 2017 2,047.00
Mar 31, 2017 -1,431.00
Dec 31, 2016 -321.00
Sep 30, 2016 122.00
Jun 30, 2016 582.00
Mar 31, 2016 338.00
Dec 31, 2015 -1,286.00
Sep 30, 2015 747.00
Jun 30, 2015 35.00
Mar 31, 2015 327.00
Dec 31, 2014 -342.00
Sep 30, 2014 -561.00
Jun 30, 2014 3.00
Mar 31, 2014 336.00
Dec 31, 2013 -1,055.00
Sep 30, 2013 67.00
Jun 30, 2013 -928.00
Mar 31, 2013 1,783.00
Dec 31, 2012 -1,745.00
Sep 30, 2012 1,327.00
Jun 30, 2012 -267.00
Mar 31, 2012 661.00
Dec 31, 2011 -721.00
Sep 30, 2011 -5.00
Jun 30, 2011 267.00
Mar 31, 2011 -97.00
Dec 31, 2010 -768.00
Sep 30, 2010 -61.00
Jun 30, 2010 -6.00
Mar 31, 2010 1,197.00
Dec 31, 2009 -70.00
Sep 30, 2009 -787.00
Jun 30, 2009 -562.00